213764-15-9

Basic information

• Product Name: 3(2H)-Pyridazinone, 5-[4-(methylsulfonyl)phenyl]-4-phenyl-
• CAS NO: 213764-15-9
• Molecular Formula: C17H14N2O3S
• Molecular Weight: 326.376
• Mol File: 213764-15-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3(2H)-Pyridazinone, 5-[4-(methylsulfonyl)phenyl]-4-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 3(2H)-Pyridazinone, 5-[4-(methylsulfonyl)phenyl]-4-phenyl-(213764-15-9)
• EPA Substance Registry System: 3(2H)-Pyridazinone, 5-[4-(methylsulfonyl)phenyl]-4-phenyl-(213764-15-9)

Safety Data

• Hazardous Substances Data: 213764-15-9(Hazardous Substances Data)

Upstream product

• 302-01-2 hydrazine 
• 185147-17-5 5-Hydroxyrofecoxib 
• 691005-66-0 (+/-)-5-bromo-4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one 
• 162011-90-7 rofecoxib 

Downstream Products

• 213763-81-6 2-cyclopropylmethyl-5-(4-methylsulfonyl)phenyl-4-phenyl-2H-pyridazin-3-one 
• 213764-17-1 4-(4-Fluorophenyl)-5-[4-(methylsulfonyl)phenyl]-2-hydropyridazin-3-one 

Relevant articles and documents

PYRIDAZINONES AS INHIBITORS OF CYCLOOXYGENASE-2

The invention encompasses the pyridazin-3-one compounds of formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a

Pyridazinones as inhibitors of cyclooxygenase-2

The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.